Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 840  

    Article Cited by others

ORIGINAL ARTICLE

Gastrointestinal side effects of the radioiodine therapy for the patients with differentiated thyroid carcinoma two days after prescription

Pashnehsaz Mehran, Takavar Abbas, Izadyar Sina, Zakariaee Seyed Salman, Mahmoudi Mahmoud, Paydar Reza, Geramifar Parham

Year : 2016| Volume: 15| Issue : 3 | Page no: 173-178

   This article has been cited by
 
1 High-Dose RAI Therapy Justified by Pathological N1a Disease Revealed by Prophylactic Central Neck Dissection for cN0 Papillary Thyroid Cancer Patients: Is it Superior to Low-Dose RAI Therapy?
Lan Wei,Lin Bai,Lina Zhao,Tianyu Yu,Qingjie Ma,Bin Ji
World Journal of Surgery. 2019;
[Pubmed]  [Google Scholar] [DOI]
2 Role of differentially expressed genes and long non-coding RNAs in papillary thyroid carcinoma diagnosis, progression, and prognosis
Wei-Yang Cai,Xiong Chen,Li-Ping Chen,Qian Li,Xiao-Jing Du,Yang-Yang Zhou
Journal of Cellular Biochemistry. 2018;
[Pubmed]  [Google Scholar] [DOI]
3 Radioprotective effect of lycopene on the gastrointestinal tract after high-dose radioiodine administration in rat models
Murat Sadic,Fadimana N. Aydinbelge,Nihat Yumusak,Emre Karakok,Aylin Akbulut,Gokhan Koca,Meliha Korkmaz
Nuclear Medicine Communications. 2017; 38(12): 1041
[Pubmed]  [Google Scholar] [DOI]

 

Read this article